MRNS - Marinus slips despite guidance raise amid delay for key readout
2023-11-07 13:31:50 ET
More on Marinus
- Evaluating Marinus: Ztalmy's Growth And Upcoming Trial Insights
- Marinus Pharmaceuticals, Inc. (MRNS) Q2 2023 Earnings Call Transcript
- Marinus Pharmaceuticals, Inc. 2023 Q2 - Results - Earnings Call Presentation
- Marinus Pharmaceuticals Q3 2023 Earnings Preview
- Marinus stock jumps 11% on financial, pipeline updates
For further details see:
Marinus slips despite guidance raise amid delay for key readout